SUBJECT INDEX 



1153 



IMP level in ascites cells, 395 



intestinal transport of, 387 



K+ fluxes in atria, 403 



K+ uptake by brain, 399 



lethal doses, 401 



lipogenesis in liver, 399 



mannose uptake, 394 



metabolism of, 386-389 



a-methylglucoside uptake, 394 



palmitate oxidation, 397 



pentose-P pathway stimulation, 393- 



394 



phosphorj-lation of, 387-389 



epinephrine effect, 387 



insulin effect, 387 



K^'s for hexokinases, 388 

 protein biosynthesis, 399 

 pyruvate decarboxylation, 396 

 pyruvate oxidation, 392, 397 

 pjTuvate utilization in ascites cells, 399 

 resistance of HeLa cells to, 388 

 respiration (endogenous), 391-392, 396- 

 397 



comparison with glucose, 396-397 

 respiration (glucose), 391-394, 397 



combined with iodoacetate, 397 

 summary of mechanisms of action on 

 carbohydrate utilization, 398 

 toxicity, 401 



transport into cerebrospinal fluid, 401 

 urinary excretion of, 388 

 utihzation by fungi, 387, 400 

 virus proliferation, 400 

 3-Deoxyglucose, 



intestinal transport of, 387 

 a-methylglucoside uptake, 394 

 6-Deoxygluco8e, 



glucose oxidation, 403 

 intestinal transport of, 403 

 intestinal transport of hexoses, 264, 403 

 a-methylglucoside uptake, 394 

 2-Deoxyglucose-6-phosphate, 

 formation of, 387-389 

 glucose transport, 390 

 glucose-6-P dehydrogenase, 390-391 

 glycogen synthetase, 391 

 oxidation of, 388 

 phosphoglucose isomerase, 390 



UDPG:a-l,4-glucan-a-4-glucosyltrans- 



ferase, 391 

 3-Deoxyglucose-6-phosphate, 



hexokinase, 380 



structure of 378 

 Deoxyguanosinemonophosphate (dGMP), 



adenylosuccinate synthetase, 467 



deoxycytidylate deaminase, 469 

 DeoxypjTidoxine, see DeoxypjTidoxol 

 Deoxypyridoxol (deoxypyridoxine, des- 



oxypyridoxine ) , 



acrodynia, 566 



blood cholesterol, 574 



blood phospholipids, 574 



carcinostasis, 576 



cysteine desulfurase, 570 



dermatitis, 577 



fatty acid biosynthesis, 574 



glutamate decarboxylase, 569-570 



growth of microorganisms, 575-576 



intestinal amino acid transport, 574 



intestinal sugar transport, 574 



leucocyte count, 577 



malignant carcinoid syndrome, 574 



phosphorylation of, 564 



pyridoxal kinase, 565 



pyridoxal-P level in tissues, 566 



p>Tidoxamine-P oxidase, 566 



p\Tidoxine levels in tissues, 566-568 



pyridoxol-P oxidase, 566 



serine biosynthesis, 570-571 



serotonin metabolism, 574 



structure of, 563 



toxicity, 562,566-567, 577-578 



Toxoplasma infections, 576 



transaminases, 569-570 



tryptophan metabolism, 572 



urinary excretion of xanthurenate, 572 



vitamin Bg deficiency, 562, 577-578 

 Deoxypyridoxol-phosphate, 



pyridoxamine-P oxidase, 566 



pyridoxol oxidation, 564 



pyridoxol-P oxidase, 566 

 5'-Deox>Tiboflavin, riboflavin biosynthe- 

 sis, 539 

 Deoxyribonuclease, 



ferricyanide, 675 



mercurials, 860 



